Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

The molecule restores the activity of neurons and neural circuits in a model of the disease.

Caring for a baby with retinopathy of prematurity (ROP) has never been easy. But mother and social visionary Silke Mader has made it her life’s work to ensure that parents dealing with ROP and other complications today get more support than she did.